Palisade Capital Management LLC Heron Therapeutics, Inc. Transaction History
Palisade Capital Management LLC
- $2.86 Billion
- Q1 2025
A detailed history of Palisade Capital Management LLC transactions in Heron Therapeutics, Inc. stock. As of the latest transaction made, Palisade Capital Management LLC holds 5,286,931 shares of HRTX stock, worth $12.3 Million. This represents 0.41% of its overall portfolio holdings.
Number of Shares
5,286,931
Previous 3,926,389
34.65%
Holding current value
$12.3 Million
Previous $6.01 Million
93.62%
% of portfolio
0.41%
Previous 0.19%
Shares
26 transactions
Others Institutions Holding HRTX
# of Institutions
175Shares Held
115MCall Options Held
2MPut Options Held
32.4K-
Rubric Capital Management LP New York, NY26.7MShares$62.2 Million0.68% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA8.5MShares$19.8 Million0.02% of portfolio
-
Black Rock Inc. New York, NY8.33MShares$19.4 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.16MShares$19 Million0.0% of portfolio
-
Velan Capital Investment Management LP Alpharetta, GA6.99MShares$16.3 Million22.07% of portfolio
About HERON THERAPEUTICS, INC.
- Ticker HRTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 118,774,000
- Market Cap $277M
- Description
- Heron Therapeutics, Inc., a biotechnology company, engages in developing treatments to address unmet patient needs. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single a...